The impact of growth factor utilization on infection risk in patients receiving bispecific monoclonal antibodies
Journal of Oncology Pharmacy Practice
Published online on November 25, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundBispecific monoclonal antibodies (BsAbs) are utilized in patients with relapsed or refractory multiple myeloma (MM) and light chain amyloidosis (AL amyloidosis) but are associated with high rates of neutropenia and infection. Granulocyte colony ...
BackgroundBispecific monoclonal antibodies (BsAbs) are utilized in patients with relapsed or refractory multiple myeloma (MM) and light chain amyloidosis (AL amyloidosis) but are associated with high rates of neutropenia and infection. Granulocyte colony ...